ehealth radio network
Cell-ing the Future: CytoImmune’s CEO Talks About Expanded Role in Cell Therapy
September 28, 2023
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins
Bringing you the latest information from health industry experts.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast